Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerCyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerEfficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerVaccine Treatment for Advanced Non-Small Cell Lung CancerCancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerPreconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) ImmunotherapyThe Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung CancerCIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung CancerStudy of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung CancerNeo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung CancerVigil™ + Nivolumab in Advanced Non-Small Cell Lung CancerSafety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung CancerPhase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung CancerDurvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLCRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and ChemotherapyCohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramA Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung CancerPembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLCAbscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung CancerChemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaT-Cell PET Imaging With [18F]F-AraG in Lung CancerA Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerDinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaComparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung CancerEvaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip PlatformA Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung CancerBATTLE-2 Program - A Biomarker-Integrated Targeted Therapy in Non-Small Cell Lung Cancer (NSCLC)Pembrolizumab-PET ImagingThe Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of TcellsSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLCNeoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung CancerAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerFludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCombination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung CancerPembrolizumab + Idelalisib for Lung Cancer StudyNIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung CarcinomaTrial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
P1050
Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysisBiomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelRecent advances of novel targeted therapy in non-small cell lung cancerSelected science: an industry campaign to undermine an OSHA hexavalent chromium standardSkin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysisBreast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysisSystematic review of the epidemiological evidence comparing lung cancer risk in smokers of mentholated and unmentholated cigarettesCancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidinOverview of asbestos issues in KoreaModifiers of exposure-response estimates for lung cancer among miners exposed to radon progenyReactive oxygen species: their relation to pneumoconiosis and carcinogenesisDiet, nutrition, and avoidable cancerRadiation and cancer risk: a continuing challenge for epidemiologists.The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancerThe role of stem cells in airway repair: implications for the origins of lung cancerEpidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issuesProteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screeningProphylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisGene mutations in lung cancer: promising predictive factors for the success of molecular therapyRespiratory carcinogenicity assessment of soluble nickel compounds.Ascorbate depletion: a critical step in nickel carcinogenesis?Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysisSoftware for Apportionment of Asbestos-Related MesotheliomasProteomic-Based Approaches for the Study of Cytokines in Lung CancerPlant Polyphenols as Chemopreventive Agents for Lung CancerThe impact of epidermal growth factor receptor mutations on patterns of disease recurrence after chemoradiotherapy for locally advanced non-small cell lung cancer: a literature review and pooled analysisTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsNon-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerTargeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerNot all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyMolecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic ImplicationsDiagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysisThird-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerIntegrated Palliative Care and Oncologic Care in Non-Small-Cell Lung CancerGene aberrations for precision medicine against lung adenocarcinomaThe Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of MesotheliumPemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures ReviewA Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-AnalysisMelatonin as a potential anticarcinogen for non-small-cell lung cancer
P921
Q58407413-49F07902-4D15-4F7B-924D-FFD17E35A22BQ58407433-1019A5A2-CF44-4084-B60D-837559C6A815Q58407457-BE0D0B74-4256-4601-ABE1-230B62D8574FQ58407507-01EF2D6B-05EF-4461-8BA8-66710DF3E6FCQ58407514-050F282D-447D-4833-9AB0-7E137EFE8E53Q58407536-901121D4-991E-4C64-BF49-6E400880DEACQ58407547-BDD4CEC7-6583-4FF5-B1C0-D7BBAD37F843Q58407549-8302CA23-E1BB-4A93-B24F-FA36FBD6B493Q58407561-7B2AC64E-1284-47D8-8476-7F25610BAEB9Q58407563-F9113259-1FD3-46B5-B19B-71B15E53B922Q58407569-65A9004C-A3C7-4FCF-B540-D77EEF954320Q58407571-115FB8D5-A35C-4C08-8B8D-B1F02A037BC1Q58407576-917D9842-6E5E-483F-8422-1AC2DE5F6819Q58407578-C3830D5A-3335-4ED3-9615-319867D698B8Q58407593-379B6661-E3A4-4C76-A7F0-24E4A2529B01Q58407600-DDE357A8-2702-4C77-94A9-FE9D7482304AQ58407601-6BDE9DF4-5CAE-418C-950C-74010C473473Q58407604-170A4D25-AA8B-4E06-BF2A-6782EBE1392AQ58407613-935E7F65-776E-4154-A452-AB5862860097Q58407619-4233824C-F68D-4573-BB72-0029DE68ABFDQ58407622-B3B84EDB-6C1C-43EC-B557-F70686887247Q58407626-07E430B0-D029-402E-A229-0D99D1F33141Q58407635-213565AE-A041-4512-B79D-DDC8981AF0FEQ58407636-71B32B98-8CFA-4A3B-9352-CA0681F2A4ECQ58407639-6EDE41C9-3D06-4106-9A62-3A5BA34D0DD1Q58407649-72CB753A-F0F0-4A1E-86A1-8AFAE659FD44Q58407651-26832F3D-7EA2-4A61-9C1E-0D917F16EF19Q58407669-3D630982-08AE-4A45-AE19-7B1F060EDFBFQ58407677-B0FF3966-9F5F-48F1-A8A9-44437175BF9BQ58407707-D1ACF399-1F69-4995-BE26-AB77C8CEAEB7Q58407710-5F2F9B1D-8727-458C-AFF6-EC9A718388C3Q58407737-5E7B74AB-FDB1-456A-8BEA-412A81631BFCQ58407740-3B573261-0E1A-4BC1-9EBE-E0A62CDA7416Q58407746-3FA2898C-500A-452C-B290-D75EA4F1F74BQ58407747-77F2A50F-F62C-4667-B316-963D5DFC69E3Q58407771-9FF33EE4-E2DA-46C1-A0F3-746A56EE2F8CQ58407774-21A4951A-0C4A-4A81-A305-EB78BC669366Q58407778-3D280326-3D40-44A4-8144-F6203061C549Q58407781-CA3E721A-F496-47BC-94CA-99D8FAC0D396Q58407793-819B7DEF-B9CC-462B-99E1-89A98692EB44
P1050
Q21089955-87DB37D1-8DE1-4FE2-925F-2F3047F1F668Q21090788-6e1ff11c-40a3-915f-46db-64df4041b865Q21092930-160842E2-BD1B-4F31-BED8-B15C9C7E348FQ21093288-EDF3DE6E-44F1-43E8-9842-661036A3A74FQ21133732-0834AD0D-CE2A-40ED-ACBE-D5A3F26D2E82Q21198839-21A32E5C-5085-4444-AA44-B06B0640D7B8Q21257188-A07BB197-B81A-470C-AC27-135CA8DE8C00Q21285045-58BEE9F3-1329-43D9-BFB5-FA3555CE4FAFQ22305627-29C8CABE-54E0-4955-814C-01BEA0C80B27Q23922921-54AB528C-6B9B-45D6-86AB-169C5BEA5D0DQ23923122-CFCD0898-43D0-4E5A-AD4A-6DF66D6318F1Q24554391-29F63E0F-4644-4875-AF2F-A9DD358E0529Q24622082-91A3C065-6D9A-4DAD-A553-BBD34ABFA0BFQ24625481-6E70341D-B5B2-497A-BE5D-A2E5EA1F1B1EQ24634069-99127810-DC63-4618-B5F0-E24ABBA6C634Q24653036-F28726B7-6258-4452-8925-34E79C8D32CAQ24685774-309F2359-1302-4C4D-BA69-384D3304758BQ24800321-15EABB7A-D5E9-4EC0-BB05-01FE889F06BAQ24809183-2D7CE772-7F8E-41ED-84A1-B7AEB0CB0A44Q24812613-D26C62ED-FE1D-4E53-B153-D2136BD78BE8Q24812869-777406C9-9FFB-448F-B1E2-14905AD385C6Q24814932-DC272617-8EBA-46D7-9577-B2AC3255AE33Q26738488-60D1893D-4683-43FC-B3B3-99752FA39B50Q26738539-825ADF41-56C4-4CA9-A328-C9D0111DD6D8Q26739975-7AC15588-0153-4A15-A7FF-9CAB444471A6Q26741041-89BC57F0-72F2-41DF-968F-3D2766E079D4Q26741318-00C5209F-3BD8-4CB1-9148-F611F912DB28Q26741814-EE77EC34-9223-40F5-8131-545D9A4C75B1Q26741998-431E56EC-DA4A-42CC-9191-30D8052219FFQ26743378-34A699BB-12E9-4D2E-B9D5-8A23487B0BD6Q26744284-C5FFFEFF-0D42-43CE-9AC2-A97B2F701339Q26744815-92641996-308E-431E-A053-E218C4A191A5Q26748767-8B861069-5EFF-4128-8612-A24ED88D177BQ26748851-90286892-8EEF-4619-A75A-E0053404EBB5Q26749199-0F433B96-52B8-489D-9254-08497B042BB4Q26749348-FF7FEB8E-46DA-402E-8811-F2FD108B2BDCQ26750451-FA52E951-2B20-43C6-8E04-CFF391F287BEQ26750670-0BCE8993-3535-4D4D-BE75-B93700DD7D52Q26750858-902DE8EB-9AB8-4F97-A7D3-CA60F980F836Q26751220-AE857C17-E671-44C4-BC67-F1880ADA770F
P921
description
disease
@en
maladie
@fr
захворваньне
@be-tarask
name
Lung timè
@ht
Lungentumor
@de
lung neoplasm
@en
lungesvulst
@nn
novotvar plic
@cs
tumeur du poumon
@fr
tumor pulmonar
@ca
tumor pulmonar
@es
опухоль лёгких
@ru
пухліна лёгкіх
@be-tarask
type
label
Lung timè
@ht
Lungentumor
@de
lung neoplasm
@en
lungesvulst
@nn
novotvar plic
@cs
tumeur du poumon
@fr
tumor pulmonar
@ca
tumor pulmonar
@es
опухоль лёгких
@ru
пухліна лёгкіх
@be-tarask
altLabel
lung tumor
@en
lungeneoplasi
@nn
neoplazma plic
@cs
plicní neoplazma
@cs
plicní novotvar
@cs
svulst i lunge
@nn
tumor de pulmó
@ca
tumor de pulmón
@es
prefLabel
Lung timè
@ht
Lungentumor
@de
lung neoplasm
@en
lungesvulst
@nn
novotvar plic
@cs
tumeur du poumon
@fr
tumor pulmonar
@ca
tumor pulmonar
@es
опухоль лёгких
@ru
пухліна лёгкіх
@be-tarask
P672
P486
P1995
P31
P486
P5642
P672
C04.588.894.797.520
C08.381.540
C08.785.520